Immunoprecise Antibodies
21 hedge funds and large institutions have $13.7M invested in Immunoprecise Antibodies in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 3 closing their positions.
Holders
21
Holders Change
+6
Holders Change %
+40%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
9
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AIC
1
AWM Investment Company
New York
|
$4.69M |
| 2 |
IC
2
Ikarian Capital
Dallas,
Texas
|
$1.47M |
| 3 |
ISL
3
Ingalls & Snyder LLC
New York
|
$5.08M |
| 4 |
CS
4
Credit Suisse
Zurich,
Switzerland
|
$328K |
| 5 |
5
Marshall Wace
London,
United Kingdom
|
$325K |
